Precision medicine and breast cancer
Certain forms of breast cancer are still difficult to cure and potentially fatal today, underscoring the urgent need for research to identify new therapeutic avenues for this disease that affects so many women.
At the IRCM, several researchers are working on this issue, including Elena Goretti, a doctoral student in Dr. Martin Sauvageau's laboratory, who is working on RNA-protein interactions during the metastatic processes of breast cancer.
The IRCM is thus proud to announce that Elena has been awarded a research grant from the Cancer Research Society (CRS). Following a rigorous selection process, the recipients (forty in all) each receive a two-year, $70,000 grant to support their innovative research aimed at better understanding and thwarting cancer. The scholarship is funded in partnership with the .
‘’It's truly gratifying to see younCanadian Institutes of Health Research - Institute of Cancer Researchg talent taking up the baton to defeat cancer in all its many guises, thanks to such innovative approaches as the study of RNA for therapeutic purposes,” says Dr. Jean-François Côté, President and Scientific Director of the IRCM, who warmly thanks the Cancer Research Society.
At the cutting edge of biomedical innovation, Martin Sauvageau's laboratory, within the RNA and Non-coding Mechanisms of Disease Research Unit, seeks to understand how non-coding RNAs and the non-coding genome have an impact on disease, in order to develop new and better therapies for a constellation of pathologies, including cancer.
Congratulations to the recipient!
